Literature DB >> 4354481

Renal failure, uncontrollable thirst, and hyperreninemia. Cessation of thirst with bilateral nephrectomy.

P W Rogers, N A Kurtzman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4354481

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  9 in total

Review 1.  Risk-benefit ratio of angiotensin antagonists versus ACE inhibitors in end-stage renal disease.

Authors:  D A Sica; T W Gehr; A Fernandez
Journal:  Drug Saf       Date:  2000-05       Impact factor: 5.606

2.  Role of bilateral nephrectomy in the treatment of renal disease and hypertension.

Authors:  W El-Said
Journal:  Int Urol Nephrol       Date:  1977       Impact factor: 2.370

3.  Non-psychogenic primary polydipsia in autoimmune chronic active hepatitis with severe hyperglobulinaemia.

Authors:  M V Tobin; A I Morris
Journal:  Gut       Date:  1988-04       Impact factor: 23.059

Review 4.  Minoxidil: a review of its pharmacological properties and therapeutic use.

Authors:  V M Campese
Journal:  Drugs       Date:  1981-10       Impact factor: 9.546

5.  Climate, thirst and renin.

Authors:  R B Flinn
Journal:  Trans Am Clin Climatol Assoc       Date:  1978

6.  [Regulation of thirst in end-stage kidney insufficiency].

Authors:  E Heidbreder; U Bahner; M Hess; H Geiger; R Götz; R Kirsten; W Rascher; A Heidland
Journal:  Klin Wochenschr       Date:  1990-11-16

7.  The clinical physiology of water metabolism. Part II: Renal mechanisms for urinary concentration; diabetes insipidus.

Authors:  R E Weitzman; C R Kleeman
Journal:  West J Med       Date:  1979-12

8.  Controlled trial of enalapril in patients with chronic fluid overload undergoing dialysis.

Authors:  B Oldenburg; G J MacDonald; S Shelley
Journal:  Br Med J (Clin Res Ed)       Date:  1988-04-16

9.  The dual blockade of the renin-angiotensin system in hemodialysis patients requires decreased dialysate sodium concentration.

Authors:  Rafał Zwiech; Agnieszka Bruzda-Zwiech
Journal:  Int Urol Nephrol       Date:  2012-11-08       Impact factor: 2.370

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.